Edgewise Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EWTX and other ETFs, options, and stocks.

About EWTX

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need.

CEO

Kevin Koch

CEOKevin Koch

Employees

Employees88

Headquarters

Boulder, Colorado

HeadquartersBoulder, Colorado

Founded

2017

Founded2017

Employees

Employees88

EWTX Key Statistics

Market cap

1.82B

Market cap1.82B

Price-Earnings ratio

-12.43

Price-Earnings ratio-12.43

Dividend yield

—

Dividend yield—

Average volume

657.97K

Average volume657.97K

High today

$19.72

High today$19.72

Low today

$18.98

Low today$18.98

Open price

$19.30

Open price$19.30

Volume

239.77K

Volume239.77K

52 Week high

$20.90

52 Week high$20.90

52 Week low

$5.12

52 Week low$5.12

Edgewise Therapeutics

Why Robinhood?

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Show more

EWTX Key Statistics

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need.